DHB-MED 100 Deus Medical

DHB-MED 100 (Dihydroboldenone Cypionate): THE HIGHLY ANABOLIC REDUCER

Active Substance: Dihydroboldenone Cypionate (DHB)

Manufacturer: Deus Medical

Pack: 1 Box of 10 Ampoules, 1 ml (100 mg/ml)

Form: Injectable

What Is Dihydroboldenone Cypionate (DHB)?

Dihydroboldenone (DHB) is a highly anabolic steroid that has gained significant popularity in recent years. It is chemically the 5-alpha-reduced form of Boldenone (Equipoise), meaning it is to Boldenone what Dihydrotestosterone (DHT) is to Testosterone. DHB is sometimes referred to as 1-Testosterone.

This specific product uses the long Cypionate ester, which allows for a sustained release of the potent hormone, requiring less frequent injections (typically once or twice per week).

Core Functions and Unique Potency

• High Androgen Receptor Affinity: DHB possesses a very high affinity for the Androgen Receptor (AR), significantly stronger than Testosterone. This high AR binding contributes directly to potent anabolic signaling.

• Potency and Selectivity: Based on animal studies, DHB is attributed an anabolic potency similar to Testosterone, but it is known to be highly anabolic with low androgenic activity (it cannot convert to DHT).

• Cutting Phase Utility: DHB is a very interesting steroid during a cutting phase because its high affinity for the AR contributes to the stimulation of lipases in adipose tissue, leading to a positive effect on fat loss.

• Dry, Quality Gains: DHB cannot aromatize to estrogen, ensuring that any muscle gains are hard, dry, and free of water retention.

Usage and Dosage Protocols (Unique Saturation Need)

DHB requires a specific consideration for dosing due to how it is metabolized in the body.

• Dosage for Saturation: DHB is partially metabolized by UDP-Glucuronosyltransferases (UGT enzymes). The product information notes that large doses are needed to saturate these enzymes. This means athletes typically need higher doses than expected to achieve peak free hormone levels. Common misuse doses range from 300 mg to 500 mg per week.

• Cycle Duration: Due to the long Cypionate ester, cycles should run for at least 10–12 weeks.

• Stacking: DHB is highly valued for stacking in cutting or lean-bulking cycles, often combined with components like Testosterone Propionate or Masteron.

Side Effects and Management Essentials

Despite being non-aromatizing, DHB carries distinct risks, particularly for injection discomfort and hormonal suppression.

• Injection Pain (PIP): DHB is notorious among users for causing significant and often painful Post Injection Pain (PIP), which is an important factor in deciding injection volume and frequency.

• Non-Aromatizing: DHB cannot aromatize, eliminating the risk of water retention and gynecomastia caused by estrogen conversion.

• Suppression: DHB is severely suppressive to natural testosterone production, requiring a mandatory Testosterone base during the cycle and a comprehensive Post Cycle Therapy (PCT) protocol afterward.

Frequently Asked Questions (FAQs)

1. How does DHB (Dihydroboldenone) differ from Boldenone (Equipoise)?

DHB is the 5-alpha-reduced form of Boldenone. The key difference is potency and aromatization. Boldenone aromatizes slightly and is moderately anabolic. DHB is non-aromatizing (dry gains) and is significantly more anabolic than Boldenone, making it a stronger compound often preferred for cutting due to its fat-loss properties.

2. Is DHB liver toxic?

No. As an injectable, non-oral compound, DHB does not carry the severe hepatotoxicity risk associated with 17-alpha-alkylated oral steroids (like Dianabol or Winstrol).

3. Why is DHB known to cause significant Post Injection Pain (PIP)?

While the exact reason is complex, many users report severe PIP with DHB, even in lower concentrations. This is thought to be related to the compound's chemical structure and the vehicle (oil) used in the preparation, which causes localized tissue irritation.

4. Does DHB require an Aromatase Inhibitor (AI)?

No. Since DHB cannot aromatize to estrogen, an AI (like Anastrozole or Letrozole) is not necessary to control DHB-related estrogen. An AI would only be needed to manage the estrogen produced by the Testosterone that must be stacked alongside DHB.